History of Cystic Fibrosis

A western blot to detect CFTR protein from different plasmid constructs.
A western blot to detect CFTR protein from different plasmid constructs.

Cystic fibrosis (CF) was first recognised over 400 years ago in Germany and is the most common autosomal recessive disorder in Caucasians (Berkow et al., 1998). It is a hereditary disease that causes certain glands to produce abnormal secretions, the most important of which affect the digestive tract, the pancreas and the airway epithelia (Hodson & Geddes, 1995).

The basic defect in CF is a decrease in chloride conductance across apical membranes accompanied by an increase in the uptake of sodium ions. Studies showed that this phenotype persisted in cultured epithelial cells indicating a specific defect in these cell types (Wright & Morton, 1968). Patch clamp analysis showed that the defect was due to the failure of an outward chloride channel to respond to phosphorylation by cyclic adenosine monophosphate (cAMP) dependent protein kinase (PKA) or to protein kinase C.

In the CF patient the result is epithelial dysfunction which affects the genitourinary tract, the pancreas, sweat glands but most significantly the lungs and airway epithelia. Increased cellular chloride and sodium concentration leads to the production of abnormal salty mucus secretions from the cells. The viscous mucus reduces the capacity of the lungs and increases the frequency of infection.

This leads to a proliferation of neutrophils and leucocytes in the lung and the immune response mediated by these cells increases the viscosity of the airway interfaces even more and contributes to the lung damage (Hodson & Geddes, 1995).

 

Site map

 

Home
News
Contact Details
Follow us on Facebook
Events & Fundraising
Careers
Site Feedback
Site Search
The CF Trust

 

Information for Patients on Our Clinical Trial
Latest Clinical Trial News
Contact Details

 

Consortium Members' Internal Website
About Us
How the Consortium Works
Profiles of the Strategy Group
Scientific Advisory Committee
Milestones
Comminuty Review
Oxford University Gene Medicine
Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial

 

Our Research
Optimisation of pDNA
Aerosol Delivery
Viral Vectors Development
Assay Development
Core Facilities
Consortium Patents

 

Clinical Programme
GL67A/pGM169
Clinical Team
Tracking Study
The Run-in Study
Single Dose Clinical Trial
Multi Dose Clinical Trial

 

Cystic Fibrosis
What is CF?
History of CF
Discovery of the CFTR Gene
What Causes CF?
CFTR Protein Structure
Cystic Fibrosis Links
Gene Therapy
Introduction to CF Gene Therapy
Why use Gene Therapy for CF?
Other CF Gene Therapy Groups
Examples of Successful Gene Therapy
Gene Therapy Links

 

Publications
Publications in Journals
Conference Posters & Presentations
Book Chapters
Lectures

 

Medical Futures Innovation Award 2011
Introductory Video
What is a Lentivirus
Production of Lentiviruses
Progress to Date
DNAVec
Photo Gallery